• Publications
  • Influence
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a
This study includes the largest cohort of patients with advanced-stage MF/SS and identifies markers with independent prognostic value, which, used together in a prognostic index, may be useful to stratifyadvanced-stage patients. Expand
Time course, clinical pathways, and long‐term hazards risk trends of disease progression in patients with classic mycosis fungoides
Mycosis fungoides is an indolent primary cutaneous T‐cell lymphoma and no data currently are available regarding the evolution over time of the risk of developing specific pathways of disease progression. Expand
Melanoma of unknown primary site: a 33-year experience at the Turin Melanoma Centre
The relatively good prognosis of unknown primary melanoma patients is confirmed, a fact that has to be taken into consideration for their management. Expand
Blood flow cytometry in Sézary syndrome: new insights on prognostic relevance and immunophenotypic changes during follow-up.
The relevance of CD26 negativity in SS diagnosis and monitoring is confirmed and the presence of rare CD26+ cases suggests that a multiparameter flow cytometry approach should be used. Expand
Skin metastases of malignant melanoma: a clinical and prognostic survey
The database of 4865 melanoma patients, who were diagnosed and followed up prospectively over a 30-year period at this institution, showed a significantly longer time to progression to visceral involvement for the group of patients with cutaneous locoregional metastases, despite a lower disease-free survival rate. Expand
Accelerated fractionation in inoperable non‐small cell lung cancer. A phase I/II study
Background. A prospective, single‐treatment‐arm, Phase I/II trial was performed to determine the tumor response to an accelerated regimen and assess the feasibility and toxic effects of this approachExpand
Targeting the ERK Signaling Pathway in Melanoma
In this review, the pharmacological, preclinical, and clinical trial data of the various MAPK pathway inhibitors are analyzed with a keen interest for their clinical applicability in the management of advanced melanoma. Expand
Heterogeneity of Circulating CD4+ Memory T-Cell Subsets in Erythrodermic Patients: CD27 Analysis Can Help to Distinguish Cutaneous T-Cell Lymphomas from Inflammatory Erythroderma
SS and IE are characterized by a different memory T-cell subset expression; CD27 expression could be used as an additional diagnostic tool in the differential diagnosis. Expand
Zosteriform Cutaneous Metastases: A Literature Meta‐Analysis and a Clinical Report of Three Melanoma Cases
Cutaneous metastases with zosteriform pattern are rare and show a wide clinicopathologic spectrum that could affect the disease course, and a meta‐analysis of literature data is presented. Expand
Wide local excision vs. Mohs Tübingen technique in the treatment of dermatofibrosarcoma protuberans: a two‐centre retrospective study and literature review
Dermatofibrosarcoma protuberans (DFSP) is a rare, low‐grade mesenchymal skin tumour, characterized by slow infiltrative growth and common local recurrence, with infrequent distant metastases.